Sign In
Buy AORT
$20.58
+0.160 (+0.784%)
At Close: Jun 03, 2026
5-Year Real-World Safety and Efficacy Data from On-X Aortic Heart Valve Low INR Post-Market Study Demonstrate Even Better Patient Outcomes Than Predicted by the PROACT IDE Study Late-Breaking 30-Day D
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
04:10pm, Monday, 22'nd Apr 2024
ATLANTA , April 22, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2024 financial resul
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
10:46am, Monday, 15'th Apr 2024
Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
04:10pm, Monday, 01'st Apr 2024
ATLANTA, April 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the
Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run?
10:16am, Friday, 29'th Mar 2024
Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are Medical Stocks Lagging Artivion (AORT) This Year?
10:46am, Thursday, 28'th Mar 2024
Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
3 Buy-Rated Small Caps Flexing Big Growth
05:31pm, Tuesday, 19'th Mar 2024
Small-cap stocks can be solid considerations for those who can handle a higher level of volatility. Analysts have recently become bullish on these three.
Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024
10:51am, Thursday, 14'th Mar 2024
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?
10:46am, Tuesday, 12'th Mar 2024
Here is how Artivion (AORT) and Astria Therapeutics, Inc. (ATXS) have performed compared to their sector so far this year.
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
04:10pm, Wednesday, 06'th Mar 2024
ATLANTA , March 6, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at th
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
10:45am, Thursday, 22'nd Feb 2024
Here is how Artivion (AORT) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
10:15am, Thursday, 22'nd Feb 2024
Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Wall Street Analysts Think Artivion (AORT) Could Surge 30.7%: Read This Before Placing a Bet
10:56am, Wednesday, 21'st Feb 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 30.7% in Artivion (AORT). While the effectiveness of this highly sought-after metric is questionable, the posit
Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript
08:22pm, Thursday, 15'th Feb 2024
Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript
Artivion (AORT) Surpasses Q4 Earnings and Revenue Estimates
06:35pm, Thursday, 15'th Feb 2024
Artivion (AORT) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to earnings of $0.10 per share a year ago.
